Lv4
770 积分 2023-08-03 加入
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation
2天前
已完结
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
1个月前
已完结
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma
2个月前
已完结
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
2个月前
已完结
Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review
3个月前
已完结
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
3个月前
已完结
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
3个月前
已完结
PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
3个月前
已完结
Insights Into the Cellular and Molecular Mechanisms Behind the Antifibrotic Effects of Nerandomilast
3个月前
已完结
Unmet needs and emerging pharmacotherapies for autoimmune connective tissue disease-associated interstitial lung diseases
3个月前
已完结
皖公网安备34019202002308
